Skip to main content

Table 3 Dichotomous CA125 prediction model in Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO)

From: Development and validation of circulating CA125 prediction models in postmenopausal women

PredictorOdds Ratio (95% CI)a
Age (per year)1.04 (1.01–1.07)
Race
 WhiteRef
 Non-white0.68 (0.47–0.99)
Body mass index (kg/m2)0.95 (0.93–0.97)
Smoking
 NeverRef
 Current0.72 (0.31–1.64)
 Former1.01 (0.78–1.31)
Pack-years among current smokers1.00 (0.98–1.02)
Pack-years among former smokers1.01 (1.00–1.01)
Hysterectomy
 NoRef
 Yes0.54 (0.41–0.73)
Time since menopause
  < 5 yearsRef
 5–9 years0.76 (0.52–1.04)
 10–14 years0.70 (0.46–1.05)
 15–19 years0.83 (0.52–1.31)
  ≥ 20 years0.96 (0.56–1.64)
Duration of HT use
 Never usersRef
  ≤ 1 year0.60 (0.41–0.87)
 2–3 years0.80 (0.55–1.15)
 4–5 years0.88 (0.60–1.29)
 6–9 years1.27 (0.94–1.71)
  ≥ 10 years1.22 (0.94–1.58)
AUC0.64 (0.61–0.66)
  1. aMutually adjusted for all other predictors in this table